UT Southwestern Medical Center is one of the few institutions in the country with a treatment and research center dedicated to mesothelioma, an otherwise rare cancer of the chest lining usually caused by asbestos exposure. The American Lung Association estimates that 2,000 to 3,000 individuals are diagnosed with mesothelioma each year in the United States.
At UT Southwestern, our medical and radiation oncologists, cardiothoracic surgeons, physician assistants, and nurses collaborate to evaluate each patient and develop a personalized plan that guides the team from diagnosis through treatment to supportive aftercare.
Once a patient is diagnosed, our comprehensive treatments include:
- Access to clinical trials
- Intensity-modulated radiation therapy (IMRT)
- Minimally invasive interventional surgery
- Nutrition therapy
- Palliative care and pain management
Our surgeons are experts in minimally invasive techniques to diagnose and treat mesothelioma. UT Southwestern has excellent surgical outcomes for mesothelioma, and we are the lead center for a national chemotherapy clinical trial.
Our specialists also have a weekly cancer conference at which every mesothelioma patient is presented in a broad-based, multidisciplinary manner.
In addition to working on clinical trials, our researchers are exploring new approaches to improve current treatments to reach better outcomes. Promising areas currently under investigation include immunotherapy and genomics.
Through all of the treatments, social workers and case managers in the Harold C. Simmons Comprehensive Cancer Center are available to help patients and their families connect with community resources for additional care and support.